MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Botulinum toxin: Clinical applications: other"

  • 2018 International Congress

    Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series

    C. Wang, E. Wang, H. Lei (Tucson, AZ, USA)

    Objective: To report increased risks of Botulinum Toxin Injection for cervical dystonia and migraine in patients with Hypermobility Ehlers Danlos Syndrome. Background: Ehlers-Danlos syndrome (EDS)…
  • 2018 International Congress

    Botulinum toxin in Restless Leg Syndrome – A Randomized Double-Blind Placebo-Controlled Study

    S. Mittal, D. Machado, D. RIchardson, D. Dubey, B. Jabbari (Bangalore, India)

    Objective: To study the efficacy of incobotulinumtoxin A (IncoA) in relieving the symptoms of restless legs syndrome (RLS) Background: RLS is a common movement disorder…
  • 2018 International Congress

    Incobotulinum toxin type A for the treatment of biceps/triceps co-contraction due to obstetrical brachial plexus lesion

    G. Ianieri, R. Marvulli, G. Gallo (Bari, Italy)

    Objective: The injection of Incobotulinum toxin type A associated with physical therapy may improve the kinematics of flexion and extension of the elbow after obstetrical…
  • 2018 International Congress

    Comparison of botulinum toxin injections in forearm flexor and extensor muscles versus pure flexor muscles for the treatment of essential hand tremor (FLEX-D ET)

    S. Patel, X. Yu, J. Lin, O. Hogue, T. Rasameesoraj, D. Hengartner, H. Fernandez (Cleveland, OH, USA)

    Objective: The aim of this study is to compare the efficacy of botulinum toxin (BoNT) injections in forearm flexors and extensor muscles versus pure flexors…
  • 2018 International Congress

    Botulinum toxin injections improve daily life activities in patients with upper limb tremor

    A. Kreisler, B. Bouchain, L. Defebvre (Lille, France)

    Objective: To describe a group of patients with an upper limb tremor refractory to per os medications and receiving Botulinum NeuroToxin type A (BoNT-A) injections.…
  • 2018 International Congress

    Assessing hemifacial spasm: The HFSG scale

    S. Simoni, N. Tambasco, E. Sacchini, E. Marsili, P. Nigro, E. Brahimi, M. Romoli, F. Paolini Paoletti, M. Filidei, P. Calabresi (Perugia, Italy)

    Objective: To create and validate an objective assessing tool to diagnose and monitor HFS and the efficacy of its treatments. Background: Hemifacial spasm (HFS), is…
  • 2018 International Congress

    Botulinum toxin in Essential Hand Tremor – A Randomized Double-Blind Placebo-Controlled study with Customized Injection Approach

    S. Mittal, D. Machado, D. Richardson, D. Dubey, B. Jabbari (Bangalore, India)

    Objective: To evaluate the safety and efficacy of incobotulinumtoxinA (IncoA) injection for treatment of Essential Tremor (ET). Background: In essential tremor and Parkinson's Disease tremor,…
  • 2018 International Congress

    Effect of Cold Compression Before Botulinum Neurotoxin Injection in Hemifacial Spasm

    P. Dhanachanvisith, T. Tantirittisak (Bangkok, Thailand)

    Objective: To compare effect of cold compression and no cold compression before Botulinum neurotoxin (BoNT) injection on severity, frequency of hemifacial spasm (HFS) and complication…
  • 2018 International Congress

    Comparison of clinical characteristics and treatment outcomes of botulinum neurotoxin in routine clinical practice between hemifacial spasm with and without the Babinski-2 sign in Thai patients: An exploratory study

    A. Suengtaworn, Y. Pitakpatapee, P. Soontrapa, C. Hurst, P. Srivanitchapoom (Bangkok, Thailand)

    Objective: To compare the clinical characteristics, along with the treatment outcomes of botulinum neurotoxin (BoNT) between HFS patients with and without the BBK-2 sign as…
  • 2018 International Congress

    The comparison of the clinical characteristics and treatment outcomes between non-troublesome and troublesome hemifacial spasm in Thai patients

    Y. Pitakpatapee, A. Suengtaworn, P. Soontrapa, P. Srivanitchapoom (Bangkok, Thailand)

    Objective: To compare the clinical characteristics and treatment outcomes after injection of botulinum neurotoxin (BoNT) type A between non-troublesome and troublesome hemifacial spasm (HFS) in…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 12
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley